Alan has over 25 years experience in drug discovery and development in the Pharmaceutical and Biotech industries and is also involved in the voluntary sector as a Trustee of the Babraham Institute.

  • Alan WattPhD MBA BSc CChem MRSC
  • Chief Executive Officer and Co-Founder
  • 07717 801296
  • e: alan.watt@xenovium.com
Chief Executive Officer and Co-Founder

Alan has over 25 years experience in drug discovery and development in the Pharmaceutical and Biotech industries and is also involved in the voluntary sector as a Trustee of the Babraham Institute.

Alan Watt holds a PhD in Drug Metabolism, an MBA from the Open Business School and has over 25 years drug discovery and development experience in the Pharmaceutical and Biotech industries. He has over 50 peer-reviewed scientific publications.

His roles have taken him from Head of Drug Metabolism and Head of In Vivo Pharmacology at Merck, to Head of Preclinical Development for the Neurology Centre of Excellence for Drug Discovery (CEDD) at GSK.

In 2008 he moved within GSK to the Immuno-inflammation CEDD, to start-up and head the Pattern Recognition Receptor Discovery Performance Unit (DPU) in Philadelphia, developing drugs for disorders of the innate immune system. In 2010 he joined Cellzome UK as VP of Therapeutics where he successfully led the company’s immunology drug discovery efforts, delivering a number of kinase inhibitor drug candidates and contributing to the successful exit to GSK in 2012. In 2013 Alan took an assignment through Xenovium as Chief Operating Officer/ EVP of R&D for Trident Pharmaceuticals, a semi-virtual biotech developing HF1020, an immunomodulatory drug for the treatment of autoimmunity and allergy

Alan also works in the voluntary sector as a Trustee of the Babraham Institute (BI), an independent charitable life sciences institute involved in biomedical research and as a Director of Babraham Institute Enterprise (BIE), the commercial arm of BI.

Autophagy Modulators - Target Discovery to Candidate Selection
Read how we helped a start-up Biotech to create a business plan and allied presentations in order to present to Pharma, Biotech and VC audiences….
Contact Us
  • Xenovium Ltd,
    Chesterford Research Park, Little Chesterford, Saffron Walden, CB10 1XL